共 50 条
- [41] ERCC1_202 Is A Prognostic Biomarker in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy JOURNAL OF CANCER, 2017, 8 (14): : 2846 - 2853
- [42] Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy CANCER RESEARCH AND TREATMENT, 2017, 49 (01): : 141 - 149
- [43] NANOG as an adverse predictive marker in advanced non-small cell lung cancer treated with platinum-based chemotherapy ONCOTARGETS AND THERAPY, 2017, 10 : 4625 - 4633
- [45] Meta-Analysis on Pharmacogenetics of Platinum-Based Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Patients PLOS ONE, 2012, 7 (06):